Eligo Bioscience

France


 
Quantité totale PI 93
Rang # Quantité totale PI 14 119
Note d'activité PI 2,9/5.0    119
Rang # Activité PI 5 759
Classe Nice dominante Produits cosmétiques et préparat...

Brevets

Marques

50 2
14 0
25 2
0
 
Dernier brevet 2025 - Method for treating c. acnes bac...
Premier brevet 2016 - Improving sequence-specific anti...
Dernière marque 2020 - ELIGO BIOSCIENCE
Première marque 2018 - ELIGOBIOTIC

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Method for treating c. acnes bacteria-associated diseases. The present invention concerns a meth...
Invention Detection and treatment of c. acnes bacteria-associated diseases. Cutibacterium acnesC. acnesC. a...
Invention Phage-derived particles for in situ delivery of dna payload into c. acnes population. The invent...
Invention Bacterial delivery vehicle, process of production and uses thereof. The present invention relate...
Invention Production of lytic phages. The present invention concerns a production bacterial cell for produ...
Invention Optimized vector for delivery in microbial populations. The present invention relates to a vecto...
Invention Production bacterial cells and use thereof in production methods. The present invention concerns...
2023 Invention Cutibacterium acnes recombinant phages, method of production and uses thereof. The invention rel...
Invention C. acnes population. C. acnes containing these vectors or modified by transduction of these phage...
Invention Microbiome modulation of a host by delivery of dna payloads with minimized spread. The present in...
Invention Production of lytic phages. The present invention concerns a production bacterial cell for produc...
Invention Production bacterial cells and use thereof in production methods. wherein said production bacteri...
Invention Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure mic...
Invention Chimeric receptor binding proteins for use in bacterial delivery vehicles. The present disclosur...
Invention Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins. The present in...
Invention Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy. The invention relat...
Invention Transcriptional control in prokaryotic cells using dna-binding repressors. Methods and compositio...
2022 Invention Chimeric receptor binding proteins resistant to proteolytic degradation. The present disclosure ...
Invention Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins. The present ...
Invention Engineered bacterial strains comprising a transgene. The present invention concerns a method to ...
Invention Engineered bifidobacterium strains comprising a transgene. The present invention concerns a meth...
Invention Methods involving bacterial strain replacement. The present invention concerns a method for reduc...
Invention Methods involving bacteroides strain replacement. BacteroidesBacteroidesBacteroidesBacteroidesBac...
Invention C. acnes phages comprising transgenes. C. acnes recombinant phages and methods of using these rec...
Invention Bacterial delivery vehicles comprising tracer nucleic acid sequences. The present disclosure rel...
Invention Sequence-specific antimicrobials by blocking dna repair. The invention relates to the improvemen...
Invention Production of lytic phages. wherein the expression of at least one of said phage structural genes...
Invention Production bacterial cells and use thereof in production methods. The present invention concerns ...
Invention Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins. A method for th...
Invention Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins for treating ...
Invention Method for killing bacteria with an engineered postbiotic. The present invention concerns a postb...
Invention Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins. The present inv...
2021 Invention Chimeric receptor binding proteins resistant to proteolytic degradation. The present disclosure p...
Invention Phage-derived particles for in situ delivery of dna payload into c. acnes population. The inventi...
Invention Method of containment of nucleic acid vectors introduced in a microbiome population. The inventi...
Invention Specific decolonization of antibiotic resistant bacteria for prophylactic purposes. The inventio...
2020 P/S Non-medicated toiletry preparations and cosmetic preparations; cosmetics; non-medicated skin crea...
2018 P/S Cosmetics; Non-medicated toiletry preparations and cosmetic products, namely, non-medicated skin ...
P/S Non-medicated toiletry preparations and cosmetic products; cosmetics; non-medicated skin creams;...